Renal and hepatic functions
The kidney and liver functions before operation are shown in Table 2, and the changes after the ablation are outlined in Figure 1. There was no significant transient allograft dysfunction in the renal transplant recipients after CA, as demonstrated by the serum creatinine (89.4±27.7 vs. 91.3±29.6, P=0.666) and eGFR (80.4±15.6 vs. 78.4±16.6, P=0.489) trends. Similarly, there was no significant transient liver dysfunction in hepatic transplant recipients after CA, as demonstrated by the AST (24.8±5.5 vs. 33.6±8.6, P=0.095) and ALT (24.6±10.5 vs. 31.6±12.9, P=0.310) trends.